Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
32
Number of overlapping holdings
82.1%
% of XPH's 39 holdings also in IHE
94.1%
% of IHE's 34 holdings also in XPH
Overlap by Weight
Sector Drift (XPH minus IHE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XPH |
Weight in IHE |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 5.1% | 26.1% | 5.1% |
|
JOHNSON & JOHNSON | 4.8% | 23.4% | 4.8% |
|
ZOETIS INC | 4.9% | 4.7% | 4.7% |
|
MERCK & CO. INC. | 4.7% | 4.7% | 4.7% |
|
ROYALTY PHARMA PLC CLASS A | 4.7% | 4.6% | 4.6% |
Position Highlights (Non-Overlapping Exposures)
XPH Overweight Relative to IHE
|
INTRA-CELLULAR THERAPIES INC | 2.8% |
|
AXSOME THERAPEUTICS, INC. | 2.8% |
 |
PERRIGO CO | 2.8% |
|
ELANCO ANIMAL HEALTH, INC. | 2.6% |
|
CYMABAY THERAPEUTICS, INC. | 2.6% |
|
AMPHASTAR PHARMACEUTICALS INC | 2.5% |
|
CASSAVA SCIENCES, INC. | 2.0% |
|
REVANCE THERAPEUTICS INC | 1.8% |
|
AMYLYX PHARMACEUTICALS, INC. | 1.8% |
|
ORGANON & CO. | 1.7% |
XPH Underweight Relative to IHE
|
ELI LILLY & CO | -20.9% |
|
JOHNSON & JOHNSON | -18.7% |
|
ATEA PHARMACEUTICALS, INC. | -0.1% |
|
PHIBRO ANIMAL HEALTH CORP-A | -0.1% |
|
MERCK & CO. INC. | 0.0% |
|
BRISTOL-MYERS SQUIBB CO | 0.1% |
|
ACLARIS THERAPEUTICS, INC. | 0.1% |
|
ROYALTY PHARMA PLC CLASS A | 0.1% |
|
VENTYX BIOSCIENCES, INC. | 0.1% |
|
VIATRIS, INC. | 0.2% |